IMNN - imunon.com Quarterly EPS earnings growth

IMNN (Imunon) - company brandmark

Diversification across oncology and virology via proprietary platforms minimizes genetic risks for Imunon, Inc. (IMNN), as evidenced by the quarterly EPS growth trajectory on the GURU.Markets terminal linear chart, where the metric stands at 44.90. Stability is guaranteed by New Jersey laboratories utilizing outsourced plasmid synthesis and a lack of geopolitical dependence, ensuring a reliable operational foundation within the US.

imunon.com (IMNN) Year-over-year earnings per share growth for the last 12 months: for the period 04/28/2023 - 11/15/2026

Summary analytical data breakdowns for imunon.com (IMNN)

- share price and consensus valuation forecast:
Stock Quotes Celsion Corporation|IMNN - Fair Value Consensus
- market capitalization statistics:
Market Capitalization Imunon Inc|IMNN - Company Buyout Price
- balance sheet net asset value indicators:
Net Assets per Single Share Imunon|IMNN - Accounting Capitalization|Market Capitalization to Book Value Ratio imunon.com|IMNN - Cumulative Company Assets
- debt level and financial liquidity data:
Total Debt to Equity Ratio Imunon, Inc.|IMNN - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Imunon, Inc.|IMNN - Company Total Debt Obligations|Debt to Book Capitalization Ratio Imunon, Inc.|IMNN - Company Long-Term Liabilities|Company Short-Term Debt Imunon|Quick Liquidity imunon.com
- earnings and market multiples details:
IMNN - Company Profit|Projected Future Earnings Imunon, Inc.|IMNN - Price to Earnings Multiple|Future Price to Earnings Imunon, Inc.|IMNN - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple IMNN|IMNN - Operating profit EBITDA|Net earnings per share (EPS TTM) Imunon|IMNN - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months imunon.com|IMNN - Net earnings per share growth this year|Expected earnings per share growth for next year Imunon, Inc.
- company sales and revenue statistics:
IMNN - Revenue and Sales Volume|Company Projected Revenue Imunon, Inc.|IMNN - Market Cap to Revenue Ratio|Price-to-Projected Revenue Ratio Celsion Corporation|IMNN - Trailing Twelve Months Revenue Growth
Analysis of all company metrics:Imunon, Inc.
Finished products of Imunon, Inc.

The reliability assessment of equity assets is based on a business's ability to convert market demand into net earnings per share. The quarterly EPS growth rate measures the speed of profit expansion, which is critical for Imunon, Inc. (IMNN) as it scales the IMNN-001 therapy: the transition from clinical trials to commercialization must be reflected in an upward trend on this chart.

Main competitors

TEM: Quarterly EPS earnings growth|Qiagen Corp - Year-over-year earnings per one share growth for the last 12 months|IONS (Ionis Pharmaceuticals) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months RGEN (Repligen)|Quarterly EPS earnings growth RNA|CRSP (CRISPR Therapeutics) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth WGS (GeneDx Holdings Corp.)|RARE: Year-over-year earnings per share growth for the last 12 months|BEAM - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months sarepta.com|TWST: Quarterly EPS earnings growth|TXG - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Intellia|Earnings per share growth in annualized terms for the last twelve months Stoke Therapeutics STOK|Quarterly EPS earnings growth BLFS|Wave Life Sciences - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth MAZE (Maze Therapeutics, Inc.)|Quarterly EPS earnings growth Sionna Pharma SION|Prime Medicine Bio - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months TSHA (Taysha)|QURE: Quarterly EPS earnings growth|MGTX - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months RGNX|SLDB: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months ocugen.com (OCGN)|Year-over-year net earnings per share change for the last twelve months PacBio Corp|Year-over-year earnings per share growth for the last twelve months Benitec Biopharma BNTC|DSGN: Year-over-year earnings per share growth for the last 12 months|RCKT - Year-over-year earnings per share growth for the last twelve months|4dmoleculartherapeutics.com (FDMT) - Year-over-year net earnings per share growth for the last 12 months|lexeotx.com (LXEO) - Year-over-year earnings per share growth for the last twelve months|Korro Bio, Inc (KRRO) - Quarterly EPS earnings growth|EDIT (editasmedicine.com) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months SLN (silence-therapeutics.com)|Year-over-year earnings per share growth for the last twelve months proqr.com (PRQR)|Codexis - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth SGMO (Sangamo Therapeutics)|Quarterly EPS earnings growth nautilus.bio NAUT|Metagenomi Inc. - Quarterly EPS earnings growth|DTIL (Precision BioSciences Inc.) - Year-over-year earnings per share growth for the last 12 months|GBIO: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Boundless Bio, Inc (BOLD)|XCUR (Exicure) - Quarterly EPS earnings growth|Phio Pharmaceuticals - Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Mustang Bio Corp (MBIO)|Quarterly EPS earnings growth TransCode (RNAZ)|Quarterly EPS earnings growth BNGO (bionanogenomics.com)|APDN (Applied DNA Sciences Inc) - Year-over-year net earnings per share trend for the last twelve months|BLUE - Year-over-year earnings per share growth for the last twelve months|ImmunoPrecise Antibodies Ltd. (IPA) - Year-over-year net earnings per share growth for the last 12 months|OMGA (Omega) - Year-over-year net earnings per share growth for the last 12 months|singulargenomics.com (OMIC) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months RGLS|Syros (SYRS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months telesisbio.com (TBIO)|TCON - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth UBX (Unity Biotechnology Inc.)